Data Strategy Consulting

A smart data strategy is essential to innovation, compliance, and performance. It is fundamental to the successful implementation of AI and new technologies into Life Science companies.

Business professionals working with charts graphs at a table

Why Do You Need a Data Strategy?

A robust data strategy is crucial, as it aligns data with business objectives, ensures clean and contextualized data, and establishes comprehensive data standards and governance.

Data Strategy Benefits

Innovation icon

Innovation and Efficiency

A streamlined operation built on the foundation of optimized data collection, storage, and utilization is a fundamental requirement for improving operational performance and...

Read More

Innovation and Efficiency

A streamlined operation built on the foundation of optimized data collection, storage, and utilization is a fundamental requirement for improving operational performance and driving innovation.

Read Less
Regulatory Sciences icon

Regulatory Compliance

Since the pharmaceutical, agrochemical, and food science industries are heavily regulated, it is imperative that an organisation's data strategy ensures that data complies with...

Read More

Regulatory Compliance

Since the pharmaceutical, agrochemical, and food science industries are heavily regulated, it is imperative that an organisation's data strategy ensures that data complies with regulations. Strategy compliance will reduce the risk of data integrity issues.

Read Less
Decentralized Clinical Trials icon

Improved Patient Outcomes

A well-defined data strategy that aligns with the business's goals and objectives will lead to improved decision-making and, ultimately, better research, which in turn leads...

Read More

Improved Patient Outcomes

A well-defined data strategy that aligns with the business's goals and objectives will lead to improved decision-making and, ultimately, better research, which in turn leads to better patient outcomes.

Read Less
Clinical technology services icon

Competitive Advantage

Data-driven decision-making will enable your organization to develop a clear advantage in the market. Data enables you to make decisions faster and with more confidence.

Competitive Advantage

Data-driven decision-making will enable your organization to develop a clear advantage in the market. Data enables you to make decisions faster and with more confidence.

Read Less
Service icon

Cost Reduction

Efficient data management with a well-defined data governance and data standards framework will reduce cycle time and inefficiencies associated with inconsistent or duplicated records....

Read More

Cost Reduction

Efficient data management with a well-defined data governance and data standards framework will reduce cycle time and inefficiencies associated with inconsistent or duplicated records. This will, in turn, lead to a reduction in baseline costs due to resource rationalization and the need for rework and error handling.

Read Less
Webinar icon

Enhanced Collaboration

Data strategies ensure better collaboration between departments and functions in your organization. This is achieved through the robust characterization of data use cases that...

Read More

Enhanced Collaboration

Data strategies ensure better collaboration between departments and functions in your organization. This is achieved through the robust characterization of data use cases that prioritizing collaboration and multi-group impact.

Read Less

How Can We Help With Your Data Strategy?

LRQA Certified ISO 9001 Logo

Our Data Strategy Consulting service offers a comprehensive approach to enhancing how your organization uses its data, tailored to your business goals and operating model. Our consultants have lab experience and scientific domain knowledge from R&D to clinical operations so we understand your challenges and can help you illustrate what success looks like.

We are also experienced in helping companies implement the FAIR principles in a way that is appropriate for your organizational policies, goals, and technical capabilities. This process is grounded in our extensive industry experience with similar data-centric initiatives as well as cross-industry collaborations and consortia (Allotrope, Pistoia, IUPAC, etc.).

Professional workers collaborating in an office

Our Data Strategy Process

Submissions icon

Data Maturity Assessment

Assessing your current data maturity level against industry-wide standard definitions enables us to work with you to develop a roadmap that will move your business up the data maturity scale. By revisiting this, your progress against the data strategy can be effectively monitored.

Expert Witness icon

Data Strategy, Governance, and Standards

By working with you to build the strong foundations of a data strategy, governance and standards, we enable you to make more effective use of your data. A comprehensive data strategy ensures alignment with your business goals and objectives. A well-defined data governance framework enhances your business data management capabilities. Clear data standards provide confidence in data quality and support your informed, data-driven decision making.

Adverse event intake icon

Use Cases

Use cases are essential considerations in defining the practical application of data, ensuring that insights align with your business objectives and drive measurable outcomes. By working with you to identify and implement clear use cases, your organization can prioritize data initiatives, optimize resource allocation, and enhance decision-making effectiveness.

Pin leading to another pin icon

What's Next

No matter where you are in your data strategy journey, we can help establish the essential foundations that lead to a clear roadmap and action plan for confident, data-driven decision-making. We can also provide comprehensive support for new implementations, including change management, communication planning, and training. This ensures you can effectively start to leverage AI and ML to drive meaningful value for your business. 

Expert Data Strategy Consulting Services

Our data strategy consulting services align your data with business goals—empowering innovation, ensuring compliance, and enabling confident, data-driven decisions.

Our Data Strategy Consultants & Experts

  • Andrew Newell Bio Photo

    Andrew Newell

    Team Lead Business Consultant

    View Bio

  • Joost Van Kempen Bio Photo

    Joost Van Kempen

    Business Consultant

    View Bio

  • Pete Bament Bio Photo

    Pete Bament

    Business Consultant

    View Bio

  • Dana Vanderwall Bio Photo

    Dana Vanderwall

    Senior Director, Digital Transformation

    View Bio

  • Michael Burns Bio Photo

    Michael Burns

    Business Consultant

    View Bio

  • Kirsty Payne Bio Photo

    Kirsty Payne

    Business Consultant

    View Bio

Andy is an experienced IT and operational leader with over 30 years of experience in the sector. With roles in operations, business technology, and IT, he has a broad understanding of digital transformation through the lenses of technology delivery and users at all levels. He has extensive experience as a business partner to operational leaders and IT technical leads.

Joost is an experienced leader in providing strategies that help organizations improve their science through better utilization of technology and data. He has been instrumental in setting up and implementing data and digitization strategies in a diverse set of international settings across both industry and academia.

Pete is an experienced data leader with over 22 years of experience working across the pharmaceutical product lifecycle, from R&D to manufacturing. He has developed a broad knowledge base through personal experience and by working closely with partners in Quality, Technical, Production, Logistics, Finance, Clinical, Data, and IT functions.

Dana Vanderwall is an innovative leader in scientific solutions for drug discovery and digital transformation, with over 25 years of experience in pharmaceutical and biopharma R&D. He has experience in biochemistry, structural biology, computational chemistry, cheminformatics, IT, and data strategy in pharmaceutical R&D, as well as product management for enterprise informatics software. Dana has extensive experience providing an interface between IT and senior R&D leadership, responsible for the planning and delivery of informatics platforms, services, and tools in alignment with scientific goals and strategy. He has also led the strategy development and implementation of an R&D-wide metadata layer.

Michael Burns has over 20 years of experience providing technical and business solutions to the pharmaceutical and biopharma R&D sector. He has experience in the Information Technology domain supporting, delivering, and managing IT solutions. He has also worked extensively as a consultant, delivering scientific software solutions, including Electronic Laboratory Notebooks, Data Management, Bioinformatics, and streamlining scientific workflows.

Mike has a proven track record of fostering understanding and collaboration across diverse groups of stakeholders.

Kirsty is a skilled technical project manager with over 20 years of experience in data management, software implementation, and data integrity management within regulatory environments, across the CRO and pharmaceutical sectors. She has a proven track record of driving process improvements, delivering training, and leading continuous enhancement initiatives.

News & Insights

Pros and Cons of Working with a CRO

July 31, 2025

Pros and Cons of Working with a CRO

Explore the pros and cons of working with a Contract Research Organization (CRO) and how ProPharma sets a new standard in clinical development success.

Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market

July 28, 2025

Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market

Learn about PADER, a crucial pharmacovigilance requirement for U.S. drug safety monitoring, and how it differs from PSUR in ensuring compliance and patient safety. Summarizing the main point of the...

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guide for Marketing Authorization Holders (MAHs)

July 25, 2025

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guid...

Learn about the crucial roles of QPPV, LPPV, and PSMF in ensuring effective pharmacovigilance and regulatory compliance for Marketing Authorization Holders (MAHs).

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Successfully Executing a Tech Transfer in a Week - ProPharma

July 29, 2025

Successfully Executing a Tech Transfer in a Week

Discover how ProPharma supported a $3B pharmaceutical tech transfer that was executed in just 3 days, relocating five complex product lines. The plan included FDA alignment, pre-approved protocols,...

Case Study Obesity – Accelerated Timelines - ProPharma

July 29, 2025

Obesity – Accelerated Timelines

A mid-size biotech needed fast U.S. market entry for an obesity trial. ProPharma activated 20 sites in 30 days and enrolled 300+ patients—meeting goals despite an increased sample size. Strategic...

Whitepapers Key Compliance Challenges in U.S. Medical Information Services - ProPharma

July 29, 2025

Key Compliance Challenges in U.S. Medical Information Services

For Medical Information (MI) teams navigating today’s evolving regulatory landscape, compliance isn’t just a requirement — it’s a strategic imperative. From managing off-label inquiries to...

Avoiding Common Pitfalls During FDA Inspections

July 29, 2025

Avoiding Common Pitfalls During FDA Inspections

Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert...

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

July 22, 2025

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

Gain rare, insider insight into the FDA’s expectations for ANDA submissions in this session led by Marshall Florence, PharmD, a former FDA reviewer who recently joined our team. With firsthand...

MAH Essentials: Ensuring Compliance for European Market Entry

July 10, 2025

MAH Essentials: Ensuring Compliance for European Market Entry

This webinar covers the key responsibilities of Marketing Authorization Applicants/Holders and Qualified Persons in the EEA/UK, including pharmacovigilance requirements, legal entity setup, and...

News & Insights

Pros and Cons of Working with a CRO

July 31, 2025

Pros and Cons of Working with a CRO

Explore the pros and cons of working with a Contract Research Organization (CRO) and how ProPharma sets a new standard in clinical development success.

Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market

July 28, 2025

Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market

Learn about PADER, a crucial pharmacovigilance requirement for U.S. drug safety monitoring, and how it differs from PSUR in ensuring compliance and patient safety. Summarizing the main point of the...

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guide for Marketing Authorization Holders (MAHs)

July 25, 2025

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guid...

Learn about the crucial roles of QPPV, LPPV, and PSMF in ensuring effective pharmacovigilance and regulatory compliance for Marketing Authorization Holders (MAHs).

Previous Post Arrow Next Post Arrow
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Successfully Executing a Tech Transfer in a Week - ProPharma

July 29, 2025

Successfully Executing a Tech Transfer in a Week

Discover how ProPharma supported a $3B pharmaceutical tech transfer that was executed in just 3 days, relocating five complex product lines. The plan included FDA alignment, pre-approved protocols,...

Case Study Obesity – Accelerated Timelines - ProPharma

July 29, 2025

Obesity – Accelerated Timelines

A mid-size biotech needed fast U.S. market entry for an obesity trial. ProPharma activated 20 sites in 30 days and enrolled 300+ patients—meeting goals despite an increased sample size. Strategic...

Whitepapers Key Compliance Challenges in U.S. Medical Information Services - ProPharma

July 29, 2025

Key Compliance Challenges in U.S. Medical Information Services

For Medical Information (MI) teams navigating today’s evolving regulatory landscape, compliance isn’t just a requirement — it’s a strategic imperative. From managing off-label inquiries to...

Previous Resource Arrow Next Resource Arrow
Avoiding Common Pitfalls During FDA Inspections

July 29, 2025

Avoiding Common Pitfalls During FDA Inspections

Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert...

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

July 22, 2025

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

Gain rare, insider insight into the FDA’s expectations for ANDA submissions in this session led by Marshall Florence, PharmD, a former FDA reviewer who recently joined our team. With firsthand...

MAH Essentials: Ensuring Compliance for European Market Entry

July 10, 2025

MAH Essentials: Ensuring Compliance for European Market Entry

This webinar covers the key responsibilities of Marketing Authorization Applicants/Holders and Qualified Persons in the EEA/UK, including pharmacovigilance requirements, legal entity setup, and...

Previous Webinar Arrow Next Webinar Arrow